Scapular Positioning in Standing Position Using Sonography
Condition(s) studied
Investigational drug(s) / intervention(s)
Scapular positioning in Standing position using Sonography: The localizer ultrasound of the shoulder is performed in an unclothed patient (at the shoulders) and comes to locate bony landmarks using the ultrasound probe as a Transcutaneous localizer.
Study summary
The objective of this study is to analyse the positioning of the scapula in standing position and compared to the supine position (CT scan) in 3 dimensions (3 rotations of the scapula) using a non-radiant, portable system, combining an ultrasound probe with marker and a camera integrated into a Tablet for the three-dimensional location of the marker (probe).
Eligibility
Primary outcome measure(s)
- Study the location of the scapula in 3 dimensions for the patient in standing position — Day 1
descriptive statistics of the population : mean and standard deviation of the 3 rotations of the scapula in each plane of reference coronal plane expressed in degree. Comparison with the supine position and analysis of any differences. - Study the location of the scapula in 3 dimensions for the patient in standing position — Day1
descriptive statistics of the population : mean and standard deviation of the 3 rotations of the scapula in each plane of reference axial plane expressed in degree. Comparison with the supine position and analysis of any differences. - Study the location of the scapula in 3 dimensions for the patient in standing position — Day 1
descriptive statistics of the population : mean and standard deviation of the 3 rotations of the scapula in each plane of reference sagittal plane expressed in degree. Comparison with the supine position and analysis of any differences.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Brest, University Hospital | Brest | France | Recruiting |
More University Hospital, Brest trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04449146 on ClinicalTrials.gov ↗ ← All trials in France